Eli Lilly recently announced the impressive results of its SURMOUNT-5 trial, highlighting Zepbound's efficacy over Wegovy in weight management. This promising development was disclosed alongside ...

Eli Huston Brown, 84, died peacefully on May 12, 2025, at his home in Oldham County, surrounded by his family and friends. He is survived by his wife, Kathy; his son, Eli H. Brown V; nephews Boyce F.

From late 2020 to the summer of 2024, Eli Lilly & Co. (NYSE: LLY) stock was on a tear, up more than 635%. Last year was a transformative year for the Indianapolis-based pharmaceutical giant ...

(Reuters) -Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk's Wegovy across five weight-loss targets such as reducing waist circumference, citing data from a head-to-head trial.

That could be bad news for leaders in this sector, including Eli Lilly (NYSE: LLY), the largest pharmaceutical company in the world by market cap. Should investors give up on the stock?

Eli Savit was elected Washtenaw County prosecutor in 2020 and re-elected in 2024. Before that, he served as senior legal counsel for the city of Detroit, under Mayor Mike Duggan. Washtenaw County ...

EASLEY, S.C. (WSPA) — An eight-year-old in Easley demonstrated bravery and fast thinking earlier this week, after noticing his neighbor’s house was on fire. Mason’s mother, Juliette ...

Eli Lilly (NYSE:LLY) on Sunday said that its drug Zepbound (tirzepatide) showed superior weight loss over Novo Nordisk's (NVO) Wegovy (semaglutide) in a Phase 3b head-to-head trial. The detailed ...

Eli Lilly & Co.’s stock soared 14% Thursday, to put it on track for its biggest one-day gain in about 25 years, after the drugmaker reported positive results from a late-stage trial of a GLP-1 ...